fullerene c60 has been researched along with Sarcoma 180 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Devasagayam, TP; Kamat, JP; Mohan, H; Priyadarsini, KI | 1 |
Chen, FS; Ikeda, T; Imaizumi, T; Iwase, Y; Kaya, Y; Momose, Y; Nishi, K; Sakurazawa, A; Umemura, S; Yumita, N | 1 |
Ikeda, T; Iwase, Y; Kuwahara, H; Nishi, K; Sadamoto, K; Shigeyama, M; Umemura, S; Watanabe, T; Yumita, N | 1 |
3 other study(ies) available for fullerene c60 and Sarcoma 180
Article | Year |
---|---|
Reactive oxygen species mediated membrane damage induced by fullerene derivatives and its possible biological implications.
Topics: Animals; Ascitic Fluid; Ascorbic Acid; Carbon; Dose-Response Relationship, Drug; Drug Antagonism; Fullerenes; Glutathione; Intracellular Membranes; Lipid Peroxidation; Microsomes, Liver; Models, Animal; Photosensitizing Agents; Rats; Reactive Oxygen Species; Sarcoma 180; Vitamin E | 2000 |
Sonodynamically-induced anticancer effects by functionalized fullerenes.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Separation; Free Radical Scavengers; Fullerenes; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nitrogen Oxides; Reactive Oxygen Species; Sarcoma 180; Ultrasonic Therapy | 2013 |
Involvement of reactive oxygen species in the enhancement of membrane lipid peroxidation by sonodynamic therapy with functionalized fullerenes.
Topics: Animals; Apoptosis; Cell Membrane; Cell Proliferation; Combined Modality Therapy; Female; Fullerenes; Lipid Peroxidation; Mice; Mice, Inbred ICR; Photosensitizing Agents; Reactive Oxygen Species; Sarcoma 180; Tumor Cells, Cultured; Ultrasonic Therapy | 2014 |